Search results
A Better Understanding of HIV's Effect on the Immune System
Plus via Yahoo News· 2 years agoA new study by Andrés Finzi, professor at the Université de Montréal (UdeM) and researcher at the...
Transcenta’s Osemitamab succeeds in Phase IIa G/GEJ cancer triple combo trial
Clinical Trials Arena via Yahoo Finance· 3 weeks agoTranscenta has revealed results showing that Osemitamab (TST001) plus Nivolumab and CAPOX improved...
Short bouts of exercise may boost efficacy of some types of cancer treatment
MedicalNewsToday via AOL· 2 weeks agoRecent research suggests that short bouts of moderate to intense exercise could boost the efficacy...
Coherus (CHRS) Gets CRL for Udenyca Onbody, Shares Down
Zacks via Yahoo Finance· 9 months agoShares of commercial-stage biopharmaceutical company Coherus BioSciences, Inc. CHRS were down 9.2%...
BOXER CAPITAL, LLC Reduces Stake in ITeos Therapeutics Inc
GuruFocus.com via Yahoo Finance· 10 months agoOn August 23, 2023, BOXER CAPITAL, LLC, a San Diego-based investment firm, reduced its stake in...
TRACON Secures FDA Nod For Early-Stage Study In Soft-Tissue Cancer
Benzinga via Yahoo Finance· 2 years agoThe FDA has signed off TRACON Pharmaceuticals Inc's (NASDAQ: TCON) initiation of a Phase 1/2 trial...
Gamida Cell Ltd. (GMDA) Q2 2022 Earnings Call Transcript
Motley Fool· 2 years agoPlease be advised that this call is being recorded at Gamida Cell's request. Now, I would like to...
INmune Bio, Inc. (NASDAQ:INMB) Q3 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 7 months agoINmune Bio, Inc. (NASDAQ:INMB) Q3 2023 Earnings Call Transcript November 1, 2023 INmune Bio, Inc....
Fate Therapeutics, Inc. (NASDAQ:FATE) Q3 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 7 months agoFate Therapeutics, Inc. (NASDAQ:FATE) Q3 2023 Earnings Call Transcript November 8, 2023 Operator:...
Q4 2023 TG Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 4 months agoParticipants Jenna Bosco; SVP, Corporate Communications; TG Therapeutics, Inc. Michael Weiss; President & CEO; TG Therapeutics, Inc. Adam Waldman; Chief Commercialization Officer; TG Therapeutics ...
